EX-21.1 4 exh211.htm EXHIBIT 21.1 EXH 21.1


Exhibit 21.1



Subsidiaries of NeoStem, Inc.

Entity
Percentage of Ownership
Location
NeoStem Therapies, Inc.
100%
United States of America
Stem Cell Technologies, Inc.
100%
United States of America
Amorcyte, LLC
100%
United States of America
CBH Acquisition LLC
100%
United States of America
China Biopharmaceuticals Holdings, Inc. (CBH)*  
100% owned by CBH Acquisition LLC
United States of America
Progenitor Cell Therapy, LLC (PCT)
100%
United States of America
NeoStem Family Storage, LLC
100% owned by PCT
United States of America
Athelos Corporation
80.1% owned by PCT
United States of America
PCT Allendale, LLC
100% owned by PCT
United States of America

* The 51% interest in Erye formerly held by our subsidiary CBH was sold on November 13, 2012.